Literature DB >> 3559567

Biogenic aldehydes in brain: on their preparation and reactions with rat brain tissue.

G E Nilsson, O Tottmar.   

Abstract

When 1 mM serotonin, dopamine, or norepinephrine was incubated with a monoamine oxidase preparation (mitochondrial membranes) in the presence of 4 mM sodium bisulfite, 85-95% of the amines were oxidized to the corresponding aldehydes. In the absence of bisulfite, the recoveries were only approximately 30%, and dark colored products were formed during the incubations. The aldehydes derived from tyramine, octopamine, methoxytyramine, and normetanephrine were also prepared by the use of this method. The bisulfite-aldehyde compounds were stable during storage at -20 degrees C. Bisulfite-free aldehyde solutions were made by diethylether extraction. When the aldehydes derived from dopamine or serotonin were incubated with rat brain homogenates, they were found to disappear in an aldehyde dehydrogenase- and aldehyde reductase-independent manner. The disappearance of the latter aldehyde was more pronounced, and the results indicated that this aldehyde may react with both proteins and phospholipids.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3559567     DOI: 10.1111/j.1471-4159.1987.tb05702.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  16 in total

1.  Inhibition and covalent modification of tyrosine hydroxylase by 3,4-dihydroxyphenylacetaldehyde, a toxic dopamine metabolite.

Authors:  Lydia M Mexas; Virginia R Florang; Jonathan A Doorn
Journal:  Neurotoxicology       Date:  2011-04-14       Impact factor: 4.294

2.  Aldehyde dehydrogenase activity in xenografted human brain tumor in nude mice. Preliminary results in human glioma biopsies.

Authors:  V Quemener; J P Moulinoux; C Martin; F Darcel; Y Guegan; J Faivre; G A Quash
Journal:  J Neurooncol       Date:  1990-10       Impact factor: 4.130

3.  Poster communications.

Authors: 
Journal:  Br J Pharmacol       Date:  1993-10       Impact factor: 8.739

4.  Catechol and aldehyde moieties of 3,4-dihydroxyphenylacetaldehyde contribute to tyrosine hydroxylase inhibition and neurotoxicity.

Authors:  Lydia M M Vermeer; Virginia R Florang; Jonathan A Doorn
Journal:  Brain Res       Date:  2012-07-31       Impact factor: 3.252

5.  Biochemical characterization of the catecholaldehyde reactivity of L-carnosine and its therapeutic potential in human myocardium.

Authors:  Margaret-Ann M Nelson; Zachariah J Builta; T Blake Monroe; Jonathan A Doorn; Ethan J Anderson
Journal:  Amino Acids       Date:  2018-09-06       Impact factor: 3.520

6.  Daidzin and its antidipsotropic analogs inhibit serotonin and dopamine metabolism in isolated mitochondria.

Authors:  W M Keung; B L Vallee
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-03       Impact factor: 11.205

7.  Inactivation of glyceraldehyde-3-phosphate dehydrogenase by the dopamine metabolite, 3,4-dihydroxyphenylacetaldehyde.

Authors:  Brigitte C Vanle; Virginia R Florang; Daryl J Murry; Arturo L Aguirre; Jonathan A Doorn
Journal:  Biochem Biophys Res Commun       Date:  2017-08-19       Impact factor: 3.575

8.  Dopamine-derived biological reactive intermediates and protein modifications: Implications for Parkinson's disease.

Authors:  Yunden Jinsmaa; Virginia R Florang; Jennifer N Rees; Lydia M Mexas; Laurie L Eckert; Erin M G Allen; David G Anderson; Jonathan A Doorn
Journal:  Chem Biol Interact       Date:  2011-01-13       Impact factor: 5.192

9.  Products of oxidative stress inhibit aldehyde oxidation and reduction pathways in dopamine catabolism yielding elevated levels of a reactive intermediate.

Authors:  Yunden Jinsmaa; Virginia R Florang; Jennifer N Rees; David G Anderson; Stefan Strack; Jonathan A Doorn
Journal:  Chem Res Toxicol       Date:  2009-05       Impact factor: 3.739

10.  Protein reactivity of 3,4-dihydroxyphenylacetaldehyde, a toxic dopamine metabolite, is dependent on both the aldehyde and the catechol.

Authors:  Jennifer N Rees; Virginia R Florang; Laurie L Eckert; Jonathan A Doorn
Journal:  Chem Res Toxicol       Date:  2009-07       Impact factor: 3.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.